Category : Digestive Health

One of the important roles played by the gut microbiota involves directing maturation of the mammalian immune system, although the molecular basis involved is still being characterized. As a result, the intimate relationships between commensal microorganisms and the host system are subject to an increasing amount of research into managing immune-related conditions. In particular, the induction of intestinal CD8 T…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

One of the important roles played by the gut microbiota involves directing maturation of the mammalian immune system, although the molecular basis involved is still being characterized. As a result, the intimate relationships between commensal microorganisms and the host system are subject to an increasing amount of research into managing immune-related conditions. In particular, the induction of intestinal CD8 T…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut Microbiota for Health is pleased to present its “Year at a Glance 2018” document! This new report is led by an editorial from Prof. Stéphane Schneider, Head of the Nutritional Support Unit in the Gastroenterology and Nutrition Department at Archet University Hospital in Nice (France), and summarizes the relevant advances in gut microbiota science in 2018. The last year…

GMFH Editing Team
GMFH Editing Team

Gut Microbiota for Health is pleased to present its “Year at a Glance 2018” document! This new report is led by an editorial from Prof. Stéphane Schneider, Head of the Nutritional Support Unit in the Gastroenterology and Nutrition Department at Archet University Hospital in Nice (France), and summarizes the relevant advances in gut microbiota science in 2018. The last year…

GMFH Editing Team
GMFH Editing Team

The use of complementary alternative medicine (CAM) is common among patients living with inflammatory bowel disease (IBD). For the purpose of this article, CAM is defined as therapies that go beyond traditional pharmacological approaches. Patients turn to CAM for many reasons, but most commonly the patient is either unhappy with their current treatment or is looking for a more holistic…

Natasha Haskey
Natasha Haskey is a Registered Dietitian and PhD student at The Centre for Microbiome and Inflammatory Research at the University of British Columbia – Okanagan (Kelowna, British Columbia, Canada). Her research work focuses on how dietary factors influence the gut microbiome, immune system and clinical disease in inflammatory bowel diseases. She is the co-author of the textbook Gut Microbiota: Interactive Effects on Nutrition and Health, which focuses on the gut microbiome as it relates to nutrition. Follow Natasha on Twitter @nhaskeyRD

The use of complementary alternative medicine (CAM) is common among patients living with inflammatory bowel disease (IBD). For the purpose of this article, CAM is defined as therapies that go beyond traditional pharmacological approaches. Patients turn to CAM for many reasons, but most commonly the patient is either unhappy with their current treatment or is looking for a more holistic…

Natasha Haskey
Natasha Haskey is a Registered Dietitian and PhD student at The Centre for Microbiome and Inflammatory Research at the University of British Columbia – Okanagan (Kelowna, British Columbia, Canada). Her research work focuses on how dietary factors influence the gut microbiome, immune system and clinical disease in inflammatory bowel diseases. She is the co-author of the textbook Gut Microbiota: Interactive Effects on Nutrition and Health, which focuses on the gut microbiome as it relates to nutrition. Follow Natasha on Twitter @nhaskeyRD

Recent research has involved genetics, altered mucosal immune responses, environmental factors and the gut microbiome as major players in the development of inflammatory bowel disease (IBD). Given that some patients do not respond to conventional treatments, scientists are currently exploring new gut microbiome-targeted therapeutic approaches to improve disease course. A new study, led by Dr. Ramnik Joseph Xavier from the…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Recent research has involved genetics, altered mucosal immune responses, environmental factors and the gut microbiome as major players in the development of inflammatory bowel disease (IBD). Given that some patients do not respond to conventional treatments, scientists are currently exploring new gut microbiome-targeted therapeutic approaches to improve disease course. A new study, led by Dr. Ramnik Joseph Xavier from the…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Traditionally, the diet low in fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) - best as a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible carbohydrates (i.e., FODMAPs) followed by reintroduction of some of them according to tolerance - has been widely used for overall gastrointestinal symptom relief in patients with irritable bowel syndrome (IBS). However, decreasing…

Andrea Hardy
Registered Dietitian, Andrea Hardy from Calgary, Canada specializes in gastrointestinal disorders and the gut microbiome. She is recognized as Canada’s gut health dietitian – educating health care professionals and the public on the pivotal role nutrition plays in gut health. You can find her at Ignite Nutrition, or on Twitter (@AndreaHardyRD).

Traditionally, the diet low in fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) - best as a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible carbohydrates (i.e., FODMAPs) followed by reintroduction of some of them according to tolerance - has been widely used for overall gastrointestinal symptom relief in patients with irritable bowel syndrome (IBS). However, decreasing…

Andrea Hardy
Registered Dietitian, Andrea Hardy from Calgary, Canada specializes in gastrointestinal disorders and the gut microbiome. She is recognized as Canada’s gut health dietitian – educating health care professionals and the public on the pivotal role nutrition plays in gut health. You can find her at Ignite Nutrition, or on Twitter (@AndreaHardyRD).

The ability to distinguish between “self” and “non-self” is the hallmark of a healthy immune system. Immune cells must be able to recognize pathogenic “non-self” antigens (i.e. microbial pathogens) and mount an appropriate immune response while remaining quiescent towards “self” agents (i.e. commensal microbes) that are harmless to our health. Nowhere else in the human body is this process more…

Megan Mouw
Megan Mouw holds a Bachelor of Science in microbiology from McGill University (Canada). Driven by her experiences at UCSF medical center in San Francisco, Megan is passionate about the role that the gut microbiota plays in maintaining health and wellness. She is currently perusing graduate studies in Microbiology and Environmental Toxicology at the University of California Santa Cruz and hopes to share her love of science through writing.

The ability to distinguish between “self” and “non-self” is the hallmark of a healthy immune system. Immune cells must be able to recognize pathogenic “non-self” antigens (i.e. microbial pathogens) and mount an appropriate immune response while remaining quiescent towards “self” agents (i.e. commensal microbes) that are harmless to our health. Nowhere else in the human body is this process more…

Megan Mouw
Megan Mouw holds a Bachelor of Science in microbiology from McGill University (Canada). Driven by her experiences at UCSF medical center in San Francisco, Megan is passionate about the role that the gut microbiota plays in maintaining health and wellness. She is currently perusing graduate studies in Microbiology and Environmental Toxicology at the University of California Santa Cruz and hopes to share her love of science through writing.

Mutations that lead to an impairment of tet methylcytosine dioxygenase 2 (Tet2) function or/and expression -  a gene that encodes an epigenetic modifier enzyme - have been related to the development of haematopoietic malignancies in both mice and humans. According to a new study in Nature by Marlies Meisel and Reinhard Hinterleitner from the University of Chicago and collaborators, gut…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

Mutations that lead to an impairment of tet methylcytosine dioxygenase 2 (Tet2) function or/and expression -  a gene that encodes an epigenetic modifier enzyme - have been related to the development of haematopoietic malignancies in both mice and humans. According to a new study in Nature by Marlies Meisel and Reinhard Hinterleitner from the University of Chicago and collaborators, gut…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

An imbalance in gut microbial communities has been associated with inflammatory bowel diseases (IBD) and research aimed at elucidating the contribution of the microbiota to inflammatory diseases has primarily focused on bacteria. Subsequent and ongoing research has characterized the fungal microbiota (called mycobiome) in patients with IBD. However, even though bacterial and fungal microbiota might be altered in IBD patients,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

An imbalance in gut microbial communities has been associated with inflammatory bowel diseases (IBD) and research aimed at elucidating the contribution of the microbiota to inflammatory diseases has primarily focused on bacteria. Subsequent and ongoing research has characterized the fungal microbiota (called mycobiome) in patients with IBD. However, even though bacterial and fungal microbiota might be altered in IBD patients,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that some subgroups of patients with irritable bowel syndrome (IBS) exhibit a different gut microbiota composition. Although previous small not blinded studies and one randomized placebo-controlled study have looked at the effectiveness of fecal microbiota transplantation (FMT) in patients with IBS, its utility in these patients remains unknown. A new randomized, double-blind placebo-controlled study, led by…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Previous research has shown that some subgroups of patients with irritable bowel syndrome (IBS) exhibit a different gut microbiota composition. Although previous small not blinded studies and one randomized placebo-controlled study have looked at the effectiveness of fecal microbiota transplantation (FMT) in patients with IBS, its utility in these patients remains unknown. A new randomized, double-blind placebo-controlled study, led by…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.